Diana Moses R.N., C.N.S., M.S., C.N.R.N.; Mark Yerby M.D., M.P.H., F.A.A.N., James Schimshock M.D.
Providence Epilepsy Services, Portland, Oregon
Vagal nerve stimulation (VNS) is an adjunctive therapy for improving seizure control in patients with epilepsy. The actual mechanism for how the VNS prevents seizures is not precisely known.
View current clinical trials investigating treatments for ALS.
View current clinical trials investigating treatments for Alzheimer’s disease. More »
Useful therapies are available for virtually every patient with multiple sclerosis. FDA-approved medications currently in use have had major beneficial impact on disease activity in many patients, but we must do better. We must develop therapies with even more potency in disease control, less potential of toxicity and improved ease of administration and patient comfort. More »
View current clinical trials investigating treatments for stroke. More »
Thrombolytic or "clot-busting" drugs offer an emergency treatment option for some people who are having a stroke. These medications, which include an agent called a tissue plasminogen activator (t-PA), halt the stroke by dissolving the blood clot that is blocking blood flow to the brain. More »
Purpose of study: To determine if Nuedexta exerts a palliative effect on speech, swallowing and salivation in patients with ALS.
Principal Investigator: Dr. Kimberly Goslin
Contact: Providence ALS Research Nurse at 503 962-1171
Sponsor: ALS Association (ALSA) and the Northeast ALS Consortium (NEALS) More »
Enter your ZIP to see local news and info
Telestroke puts stroke experts "in the room" 24/7 in hospitals across Oregon and southern Washington.Learn More »